Stoke Therapeutics presents data on ADOA treatment STK-002

Mirum’s maralixibat meets primary endpoint in liver disease trial

Investing.com · News 12m ago

Strategy buys 250 bitcoin, repurchases $192M preferred stock

Investing.com · News 12m ago

IonQ to acquire cybersecurity firm Elisity for up to $1.3B

Investing.com · News 12m ago

Humacyte’s phase 3 dialysis access trial results to be presented

Investing.com · News 12m ago

Steris to acquire Xodus Medical for $2.1 billion

Investing.com · News 12m ago

Freshworks to acquire Torii for SaaS and AI spend management

Investing.com · News 12m ago

Western Digital stock analysis: Buy after recent selloff?

Investing.com · News 13m ago

Guggenheim raises Everpure stock price target to $215 on hyperscaler growth

Investing.com · News 13m ago

Guggenheim raises Elevance stock price target to $460 on earnings outlook

Investing.com · News 13m ago

Cantor Fitzgerald reiterates Kodiak AI stock rating on driverless progress

Investing.com · News 13m ago